Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-04-28

Clinical Trial Update: Validation of Child-Turcotte-Pugh-Kumar (CTPK) Score in Predicting Short Term Mortality in Patients With Liver Cirrhosis

View source ↗

Summary

A clinical trial update evaluating the Child-Turcotte-Pugh-Kumar (CTPK) scoring system for predicting short-term mortality in patients with cirrhosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Sir Ganga Ram Hospital | Conditions: Cirrhosis | Status: UNKNOWN